These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8800862

  • 1. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
    Suto Y, Ametani M, Kamba M, Sugihara S.
    Br J Radiol; 1996 Mar; 69(819):201-5. PubMed ID: 8800862
    [Abstract] [Full Text] [Related]

  • 2. Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma.
    Suto Y, Shimatani Y.
    Br J Radiol; 1995 Feb; 68(806):116-20. PubMed ID: 7735739
    [Abstract] [Full Text] [Related]

  • 3. Optimum conditions for iron colloid enhanced fast spin echo imaging in hepatocellular carcinoma.
    Sugihara S, Suto Y, Yoshida K.
    Br J Radiol; 1997 Aug; 70(836):791-7. PubMed ID: 9486042
    [Abstract] [Full Text] [Related]

  • 4. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
    Suto Y, Kato T, Matsuo T, Kamba M, Shimatani Y, Ohuchi Y, Nakamura K, Ohta Y.
    Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
    [Abstract] [Full Text] [Related]

  • 5. A study of chondroitin sulfate iron colloid as a liver specific MR contrast agent.
    Hussain MZ, Ohtomo K, Kachi K, Uchiyama G, Itai Y.
    Radiat Med; 1994 May; 12(1):1-5. PubMed ID: 8016397
    [Abstract] [Full Text] [Related]

  • 6. Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma. Comparison with CT during arterial portography.
    Kamba M, Suto Y, Kato T.
    Acta Radiol; 1994 Nov; 35(6):570-5. PubMed ID: 7946680
    [Abstract] [Full Text] [Related]

  • 7. Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma.
    Suto Y, Kodama F, Kamba M, Ohta Y.
    Acta Radiol; 1995 Jan; 36(1):102-5. PubMed ID: 7833161
    [Abstract] [Full Text] [Related]

  • 8. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
    Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf KJ, Albrecht T.
    AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
    [Abstract] [Full Text] [Related]

  • 9. Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging.
    Chou CT, Chen RC, Chen WT, Lii JM.
    Clin Radiol; 2009 Jan; 64(1):22-9. PubMed ID: 19070694
    [Abstract] [Full Text] [Related]

  • 10. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X, Xu YK, Huang QL, Wu YK.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [Abstract] [Full Text] [Related]

  • 11. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma.
    Saito K, Araki Y, Park J, Metoki R, Katsuyama H, Nishio R, Kakizaki D, Moriyasu F, Tokuuye K.
    J Magn Reson Imaging; 2010 Jul; 32(1):229-34. PubMed ID: 20578029
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of iron colloid-enhanced MRI in differentiating experimental hepatocellular carcinoma from hyperplastic nodules in rats: analysis by microautoradiography.
    Suto Y, Kodama F.
    Br J Radiol; 1996 Dec; 69(828):1139-44. PubMed ID: 9135470
    [Abstract] [Full Text] [Related]

  • 13. Characterizing hepatocellular carcinoma using multi-breath-hold two-dimensional susceptibility-weighted imaging: comparison to conventional liver MRI.
    Tao R, Zhang J, Dai Y, You Z, Fan Y, Cui J, Wang J.
    Clin Radiol; 2012 Dec; 67(12):e91-7. PubMed ID: 22981726
    [Abstract] [Full Text] [Related]

  • 14. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C.
    Acta Radiol Suppl; 1998 Dec; 415():1-31. PubMed ID: 9571956
    [Abstract] [Full Text] [Related]

  • 15. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
    Suto Y, Shimatani Y, Kato T, Kamba M, Ohuchi Y, Kodama F, Kato T, Ohta Y.
    Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
    [Abstract] [Full Text] [Related]

  • 16. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN, Francis IR, Herfkens RJ, Jeffrey RB, Glazer GM, Foo TK, Shimakawa A, Pelc NJ.
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of AMI-25 enhanced MR imaging and enhanced helical CT for liver tumors].
    Yamamoto K, Shimizu T, Hiraishi K, Ashina K, Sagami A, Aratake K, Maeda H, Matsui R, Kawai T, Narabayashi I.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):1-6. PubMed ID: 7899060
    [Abstract] [Full Text] [Related]

  • 18. Hepatocellular carcinoma exhibiting a concentric structure of different histologic grades: evaluation by chondroitin sulfate iron colloid-enhanced MR imaging.
    Kamba M, Suto Y, Kodama F, Ohta Y, Kobayashi J, Horie Y, Kawasaki H.
    J Magn Reson Imaging; 1996 Jan; 6(2):406-8. PubMed ID: 8859586
    [Abstract] [Full Text] [Related]

  • 19. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ, Kim MJ, Kim KW.
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.